药品注册申请号:017874
申请类型:NDA (新药申请)
申请人:BAXTER HLTHCARE CORP
申请人全名:BAXTER HEALTHCARE CORP
产品信息
产品号商品名活性成分剂型/给药途径规格/剂量参比药物(RLD)生物等效参考标准(RS)治疗等效代码该申请号批准日期该产品号批准日期市场状态
001 TRANSDERM SCOP SCOPOLAMINE SYSTEM;TRANSDERMAL 1MG/72HR Yes Yes AB 1979/12/31 Approved Prior to Jan 1, 1982 Prescription
批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期提交号审批结论申请内容分类审评优先级;罕用药状态通知信、审评文件、说明书、包装标签备注
2024/03/01 SUPPL-51(补充) Approval Labeling STANDARD
2019/03/01 SUPPL-44(补充) Approval Labeling STANDARD
2019/03/01 SUPPL-43(补充) Approval Efficacy STANDARD
2017/09/13 SUPPL-41(补充) Approval Labeling STANDARD
2017/07/17 SUPPL-42(补充) Approval STANDARD
2013/05/15 SUPPL-40(补充) Approval Manufacturing (CMC) STANDARD
2013/04/30 SUPPL-38(补充) Approval Labeling STANDARD
2007/01/10 SUPPL-35(补充) Approval Labeling STANDARD
2002/03/22 SUPPL-32(补充) Approval Labeling STANDARD
2001/07/26 SUPPL-27(补充) Approval Labeling STANDARD
2001/07/26 SUPPL-18(补充) Approval Labeling
2000/05/30 SUPPL-30(补充) Approval Manufacturing (CMC) STANDARD
1998/06/19 SUPPL-29(补充) Approval Manufacturing (CMC) STANDARD
1996/10/07 SUPPL-28(补充) Approval Manufacturing (CMC) STANDARD
1994/05/31 SUPPL-26(补充) Approval Manufacturing (CMC) STANDARD
1993/06/28 SUPPL-24(补充) Approval Manufacturing (CMC) STANDARD
1993/02/10 SUPPL-25(补充) Approval Manufacturing (CMC) STANDARD
1992/03/05 SUPPL-23(补充) Approval Manufacturing (CMC) STANDARD
1990/07/10 SUPPL-22(补充) Approval Manufacturing (CMC) STANDARD
1988/10/03 SUPPL-17(补充) Approval Manufacturing (CMC) STANDARD
1988/03/17 SUPPL-16(补充) Approval Manufacturing (CMC) STANDARD
1984/07/25 SUPPL-14(补充) Approval Manufacturing (CMC) STANDARD
1982/06/02 SUPPL-13(补充) Approval Manufacturing (CMC) STANDARD
1981/11/02 SUPPL-11(补充) Approval Manufacturing (CMC) STANDARD
1981/10/27 SUPPL-9(补充) Approval Labeling
1981/04/10 SUPPL-5(补充) Approval Manufacturing (CMC) STANDARD
1981/02/09 SUPPL-6(补充) Approval Manufacturing (CMC) STANDARD
1980/01/28 SUPPL-1(补充) Approval Manufacturing (CMC) STANDARD
1979/12/31 ORIG-1(原始申请) Approval Type 3 - New Dosage Form STANDARD
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号专利号专利过期日是否物质专利是否产品专利专利用途代码撤销请求提交日期专利下载备注
与本品相关的市场独占权保护信息
关联产品号独占权代码失效日期备注
与本品治疗等效的药品
活性成分:SCOPOLAMINE 剂型/给药途径:SYSTEM;TRANSDERMAL 规格:1MG/72HR 治疗等效代码:AB
申请号产品号申请类型商品名活性成分剂型/给药途径规格市场状态RLDRSTE Code产品号批准日期申请人
017874 001 NDA TRANSDERM SCOP SCOPOLAMINE SYSTEM;TRANSDERMAL 1MG/72HR Prescription Yes Yes AB Approved Prior to Jan 1, 1982 BAXTER HLTHCARE CORP
078830 001 ANDA SCOPOLAMINE SCOPOLAMINE SYSTEM;TRANSDERMAL 1MG/72HR Prescription No No AB 2015/01/30 PADAGIS US
203753 001 ANDA SCOPOLAMINE SCOPOLAMINE SYSTEM;TRANSDERMAL 1MG/72HR Prescription No No AB 2019/06/19 MYLAN TECHNOLOGIES
212342 001 ANDA SCOPOLAMINE SCOPOLAMINE SYSTEM;TRANSDERMAL 1MG/72HR Prescription No No AB 2020/11/24 RICONPHARMA LLC
208769 001 ANDA SCOPOLAMINE SCOPOLAMINE SYSTEM;TRANSDERMAL 1MG/72HR Prescription No No AB 2022/01/10 ACTAVIS LABS UT INC
215329 001 ANDA SCOPOLAMINE SCOPOLAMINE SYSTEM;TRANSDERMAL 1MG/72HR Prescription No No AB 2024/05/06 RHODES PHARMS
217893 001 ANDA SCOPOLAMINE SCOPOLAMINE SYSTEM;TRANSDERMAL 1MG/72HR Prescription No No AB 2024/08/29 ZYDUS PHARMS
更多信息
药品NDC数据与药品包装、标签说明书
©2006-2024 DrugFuture->U.S. FDA Drugs Database